Skip to main
  1. Stocks
  2. Colgate-Palmolive
  3. Forecast
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 31%
Buy 38%
Hold 31%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive is positioned to benefit from a quality 3Q beat-and-raise, with organic sales up 3.6% driven by Emerging Markets growth of 5.4% and operating leverage from 1.7% volume/mix gains that lifted gross margin and EPS. Its bull case is reinforced by international strength across LatAm, APAC, and EMEA, Hill’s Pet Nutrition growth of 5.7%, and management’s ability to execute productivity programs that support FY26 gross margin of 60.4% and EPS growth of 6%. Although North America remains a work in progress, early signs of toothpaste share improvement, a more favorable category backdrop, and a stronger 2027 innovation pipeline suggest the company can sustain momentum while narrowing its share gap.

Bears say

Colgate-Palmolive is facing a fundamental earnings-quality problem because its North America business remains a growth drag, with Q3 organic sales down 1.6% and volumes down 3%, while the division’s operating margin fell 210 bps year over year to 19.5%. The company also appears structurally disadvantaged in oral care, where competition from P&G and Haleon has exposed innovation gaps in whitening and premium therapeutics, and its broader toothpaste portfolio is priced below premium peers, limiting mix and margin upside. On top of that, elevated commodity, freight, and logistics costs are expected to persist into 2027, while emerging-market currency volatility and recessionary pressure could further weigh on top-line growth and profitability.

Colgate-Palmolive (CL) has been analyzed by 16 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 38% recommend Buy, 31% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Colgate-Palmolive (CL) Analyst Forecast & Price Prediction

Get the latest Colgate-Palmolive (CL) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Colgate-Palmolive (CL)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 16 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $101.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $101.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Colgate-Palmolive (CL) Analyst Forecast & Price Prediction

Get the latest Colgate-Palmolive (CL) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Colgate-Palmolive (CL)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover CL stock data and trends